The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy.
Severe right ventricular hypertrophy (SRVH) is a rare phenotype in hypertrophic cardiomyopathy (HCM) for which limited information is available. This study was undertaken to investigate the clinical, prognostic and genetic characteristics of HCM patients with SRVH.HCM with SRVH was defined as HCM wi...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5360271?pdf=render |
id |
doaj-e7e15e3eaaf04c9db26bfb8fb85e18fc |
---|---|
record_format |
Article |
spelling |
doaj-e7e15e3eaaf04c9db26bfb8fb85e18fc2020-11-25T01:45:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01123e017411810.1371/journal.pone.0174118The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy.Xiying GuoChaomei FanLei TianYanling LiuHongyue WangShihua ZhaoFujian DuanXiuling ZhangXing ZhaoFengqi WangHongguang ZhuAiqing LinXia WuYishi LiSevere right ventricular hypertrophy (SRVH) is a rare phenotype in hypertrophic cardiomyopathy (HCM) for which limited information is available. This study was undertaken to investigate the clinical, prognostic and genetic characteristics of HCM patients with SRVH.HCM with SRVH was defined as HCM with a maximum right ventricular wall thickness ≥10 mm. Whole-genome sequencing (WGS) was performed in HCM patients with SRVH. Multivariate Cox proportional hazards regression models were used to identify risk factors for cardiac death and events in HCM with SRVH. Patients with apical hypertrophic cardiomyopathy (ApHCM) were selected as a comparison group. The clinical features and outcomes of 34 HCM patients with SRVH and 273 ApHCM patients were compared.Compared with the ApHCM group, the HCM with SRVH group included younger patients and a higher proportion of female patients and also displayed higher cardiovascular morbidity and mortality. The multivariate Cox proportional hazards regression models identified 2 independent predictors of cardiovascular death in HCM patients with SRVH, a New York Heart Association class ≥III (hazard ratio [HR] = 8.7, 95% confidence interval (CI): 1.43-52.87, p = 0.019) and an age at the time of HCM diagnosis ≤18 (HR = 5.5, 95% CI: 1.24-28.36, p = 0.026). Among the 11 HCM patients with SRVH who underwent WGS, 10 (90.9%) were identified as carriers of at least one specific sarcomere gene mutation. MYH7 and TTN mutations were the most common sarcomere mutations noted in this study. Two or more HCM-related gene mutations were observed in 9 (82%) patients, and mutations in either other cardiomyopathy-related genes or ion-channel disease-related genes were found in 8 (73%) patients.HCM patients with SRVH were characterized by poor clinical outcomes and the presentation of multiple gene mutations.http://europepmc.org/articles/PMC5360271?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xiying Guo Chaomei Fan Lei Tian Yanling Liu Hongyue Wang Shihua Zhao Fujian Duan Xiuling Zhang Xing Zhao Fengqi Wang Hongguang Zhu Aiqing Lin Xia Wu Yishi Li |
spellingShingle |
Xiying Guo Chaomei Fan Lei Tian Yanling Liu Hongyue Wang Shihua Zhao Fujian Duan Xiuling Zhang Xing Zhao Fengqi Wang Hongguang Zhu Aiqing Lin Xia Wu Yishi Li The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy. PLoS ONE |
author_facet |
Xiying Guo Chaomei Fan Lei Tian Yanling Liu Hongyue Wang Shihua Zhao Fujian Duan Xiuling Zhang Xing Zhao Fengqi Wang Hongguang Zhu Aiqing Lin Xia Wu Yishi Li |
author_sort |
Xiying Guo |
title |
The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy. |
title_short |
The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy. |
title_full |
The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy. |
title_fullStr |
The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy. |
title_full_unstemmed |
The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy. |
title_sort |
clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
Severe right ventricular hypertrophy (SRVH) is a rare phenotype in hypertrophic cardiomyopathy (HCM) for which limited information is available. This study was undertaken to investigate the clinical, prognostic and genetic characteristics of HCM patients with SRVH.HCM with SRVH was defined as HCM with a maximum right ventricular wall thickness ≥10 mm. Whole-genome sequencing (WGS) was performed in HCM patients with SRVH. Multivariate Cox proportional hazards regression models were used to identify risk factors for cardiac death and events in HCM with SRVH. Patients with apical hypertrophic cardiomyopathy (ApHCM) were selected as a comparison group. The clinical features and outcomes of 34 HCM patients with SRVH and 273 ApHCM patients were compared.Compared with the ApHCM group, the HCM with SRVH group included younger patients and a higher proportion of female patients and also displayed higher cardiovascular morbidity and mortality. The multivariate Cox proportional hazards regression models identified 2 independent predictors of cardiovascular death in HCM patients with SRVH, a New York Heart Association class ≥III (hazard ratio [HR] = 8.7, 95% confidence interval (CI): 1.43-52.87, p = 0.019) and an age at the time of HCM diagnosis ≤18 (HR = 5.5, 95% CI: 1.24-28.36, p = 0.026). Among the 11 HCM patients with SRVH who underwent WGS, 10 (90.9%) were identified as carriers of at least one specific sarcomere gene mutation. MYH7 and TTN mutations were the most common sarcomere mutations noted in this study. Two or more HCM-related gene mutations were observed in 9 (82%) patients, and mutations in either other cardiomyopathy-related genes or ion-channel disease-related genes were found in 8 (73%) patients.HCM patients with SRVH were characterized by poor clinical outcomes and the presentation of multiple gene mutations. |
url |
http://europepmc.org/articles/PMC5360271?pdf=render |
work_keys_str_mv |
AT xiyingguo theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT chaomeifan theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT leitian theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT yanlingliu theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT hongyuewang theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT shihuazhao theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT fujianduan theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT xiulingzhang theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT xingzhao theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT fengqiwang theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT hongguangzhu theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT aiqinglin theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT xiawu theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT yishili theclinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT xiyingguo clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT chaomeifan clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT leitian clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT yanlingliu clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT hongyuewang clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT shihuazhao clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT fujianduan clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT xiulingzhang clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT xingzhao clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT fengqiwang clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT hongguangzhu clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT aiqinglin clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT xiawu clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy AT yishili clinicalfeaturesoutcomesandgeneticcharacteristicsofhypertrophiccardiomyopathypatientswithsevererightventricularhypertrophy |
_version_ |
1725022531035856896 |